Peptide Library

46 peptide reference cards — mechanism of action, typical dosing, cycle length, and synergistic compounds. Understand what each peptide does and how it fits into a protocol.

Ask FoxAIPeptide research chat backed by the PeptideFox knowledge graph and peer-reviewed papers.

Peptide reference cards

Metabolic

5-Amino-1MQ

Body recomp via NNMT inhibition

Mechanism

Inhibits NNMT, shifts methyl/NAD metabolism

Typical dose

250-500 mcg daily

Cycle length

4-6 weeks

Frequency

Daily

Clinical benefits

Fat loss
Metabolic flexibility
Insulin sensitivity

Synergistic compounds

NAD+AOD-9604L-CarnitineMOTS-cRetatrutideTesamorelin

Cognitive & Nootropic

Adamax

High-potency Semax analog

Mechanism

Adamantyl-modified neurotrophic peptide; BDNF/TrkB and dopamine optimization

Typical dose

50-150 mcg daily

Cycle length

2 weeks

Frequency

Daily

Clinical benefits

Cognitive drive
Extended focus (10-20h)
Neuroplasticity

Synergistic compounds

Selank

Metabolic

AOD-9604

Fat mobilization support

Mechanism

Lipolysis signaling via GH C-terminal fragment

Typical dose

250-500 mcg daily

Cycle length

12-16 weeks

Frequency

Daily

Clinical benefits

Fat mobilization
Gentle cut support
No hyperglycemia

Synergistic compounds

5-Amino-1MQL-CarnitineNAD+RetatrutideTesamorelinTirzepatide

Healing & Tissue Repair

ARA-290

Neuropathic pain & nerve healing

Mechanism

Innate repair receptor agonist, tissue-protective signaling

Typical dose

4 mg daily

Cycle length

4-12 weeks

Frequency

Daily

Clinical benefits

Neuropathic pain reduction
Nerve injury recovery
Improved sleep

Synergistic compounds

NAD+SS-31BPC-157

Healing & Tissue Repair

BPC-157

Body protection compound

Mechanism

Angiogenesis, NO signaling, fibroblast migration

Typical dose

250-500 mcg daily

Cycle length

4-12 weeks

Frequency

Daily

Clinical benefits

Systemic healing
Gut barrier support
Tissue regeneration

Synergistic compounds

TB-500GHK-CuNAD+KPVARA-290CartalaxPEAThymosin Beta-4

Healing & Tissue Repair

Cartalax

Cartilage & joint support

Mechanism

Gene-expression normalization in chondrocytes

Typical dose

2 mg daily

Cycle length

4-8 weeks

Frequency

Daily

Clinical benefits

Joint comfort
Cartilage symptoms
Reduced stiffness

Synergistic compounds

NAD+BPC-157GHK-CuTB-500

Growth Hormone Axis

CJC-1295 DAC

Extended GHRH analog for pulsatile GH

Mechanism

GHRH-R agonist with albumin-binding DAC tail; 5-8 day half-life

Typical dose

2-4 mg weekly

Cycle length

4-12 weeks

Frequency

Weekly

Clinical benefits

Pulsatile GH restoration
Body recomposition
Deep sleep improvement

Synergistic compounds

Ipamorelin

Growth Hormone Axis

CJC-1295 no-DAC

Short-acting GHRH analog (Mod GRF 1-29)

Mechanism

GHRH-R agonist; ~30 min half-life, daily/multi-daily cadence

Typical dose

100-300 mcg daily

Cycle length

8-12 weeks

Frequency

Daily

Clinical benefits

Pulsatile GH release
Sleep & recovery
Daily-cadence GHRH

Synergistic compounds

Ipamorelin

Cognitive & Nootropic

DSIP

Sleep onset & circadian support

Mechanism

Modulates sleep-arousal networks via hypothalamic signaling

Typical dose

100-400 mcg daily

Cycle length

2-4 weeks

Frequency

Daily

Clinical benefits

Faster sleep onset
Fewer awakenings
Improved sleep continuity

Synergistic compounds

OxytocinPinealonSelankSemaxVIP

Anti-Aging

Epitalon

Circadian & longevity support

Mechanism

Telomere/clock-gene regulation, melatonin modulation

Typical dose

5-10 mg daily

Cycle length

1.5-3 weeks

Frequency

Daily

Clinical benefits

Sleep quality
Circadian regularity
Stress resilience

Synergistic compounds

PinealonThymalin

Anti-Aging

FOXO4-DRI

Senolytic research peptide (preclinical)

Mechanism

D-retro-inverso TAT-fused peptide; disrupts FOXO4-p53 to clear senescent cells

Typical dose

1-5 mg every 3 days

Cycle length

1-2 weeks

Frequency

Every 3 days

Clinical benefits

Senescent cell clearance (mouse)
Tissue function rebound (mouse)
Inflammation modulation (mouse)

Synergistic compounds

NAD+SS-31MOTS-cEpitalonPinealonGHK-CuThymosin α-1

Cosmetic

GHK-Cu

Collagen synthesis & skin remodeling

Mechanism

Up-regulates collagen/elastin, down-modulates MMPs

Typical dose

1-2.5 mg 3×/week

Cycle length

6-8 weeks

Frequency

3×/week

Clinical benefits

Skin remodeling
Scar quality
Hair support

Synergistic compounds

BPC-157TB-500NAD+CartalaxKPVThymosin Beta-4

Growth Hormone Axis

GHRP-2

Legacy ghrelin-receptor GH pulse

Mechanism

GHS-R1a agonist; GH pulse with cortisol/prolactin spillover

Typical dose

100-300 mcg daily

Cycle length

8-12 weeks

Frequency

Daily

Clinical benefits

GH pulse amplification
Appetite stimulation
Legacy class comparator

Synergistic compounds

Sermorelin

Growth Hormone Axis

GHRP-6

Older appetite-heavy GH secretagogue

Mechanism

GHS-R1a agonist; heavier hunger, cortisol, and prolactin than newer agents

Typical dose

100-300 mcg daily

Cycle length

8-12 weeks

Frequency

Daily

Clinical benefits

Hunger and weight gain
GH pulse
Class comparator

Synergistic compounds

Sermorelin

Immune Modulators

Glutathione (GSH)

Master antioxidant & detox substrate

Mechanism

Tripeptide redox buffer; NADPH-dependent recycling; phase 2 detox conjugation

Typical dose

200-600 mg 3×/week

Cycle length

4-12 weeks

Frequency

3×/week

Clinical benefits

Oxidative stress protection
Detoxification support
Mitochondrial function

Synergistic compounds

NAD+KPVPEAThymosin α-1ThymulinVIP

HPTA Axis

hCG

Testicular maintenance & fertility

Mechanism

Mimics LH; stimulates Leydig/theca cells

Typical dose

150-500 IU every other day

Cycle length

3-24 weeks

Frequency

Every other day

Clinical benefits

Testicular volume maintenance
Libido
Semen quality

Synergistic compounds

Kisspeptin-10

Growth Hormone Axis

hGH

Master anabolic hormone

Mechanism

191-aa pituitary hormone; JAK2/STAT5; IGF-1 axis

Typical dose

0.5-4 IU daily

Cycle length

8-12 weeks

Frequency

Daily

Clinical benefits

Body recomposition
Cellular regeneration
Deep sleep & skin/bone health

Synergistic compounds

NAD+BPC-157TB-500GHK-CuL-CarnitineMOTS-cSS-31

Growth Hormone Axis

IGF-1 LR3

Myogenic driver for tissue repair

Mechanism

Modified IGF-1 with extended half-life; PI3K-Akt-mTOR; satellite-cell proliferation

Typical dose

20-80 mcg daily

Cycle length

3-4 weeks

Frequency

Daily

Clinical benefits

Muscle repair
Satellite cell activation
Collagen synthesis

Synergistic compounds

BPC-157TB-500TesamorelinIpamorelin

Growth Hormone Axis

Ipamorelin

Clean GH secretagogue

Mechanism

Selective GHS-R agonist; GH release without prolactin/cortisol

Typical dose

100-300 mcg daily

Cycle length

8-12 weeks

Frequency

Daily

Clinical benefits

Deeper sleep
Enhanced recovery
Improved training capacity

Synergistic compounds

GLP-1sCJC-1295 no-DACSermorelinTesamorelinCJC-1295 DAC

HPTA Axis

Kisspeptin-10

HPG-axis support

Mechanism

Stimulates GnRH neurons; pulsatile LH/FSH release

Typical dose

100-500 mcg 3×/week

Cycle length

4-8 weeks

Frequency

3×/week

Clinical benefits

Libido improvement
LH/FSH elevation
Testicular function

Synergistic compounds

hCG

Healing & Tissue Repair

KPV

Anti-inflammatory peptide

Mechanism

α-MSH fragment, NF-κB down-regulation, mast-cell stabilization

Typical dose

200-500 mcg daily

Cycle length

4-8 weeks

Frequency

Daily

Clinical benefits

Mucosal inflammation
IBD symptom support
Post-injury swelling

Synergistic compounds

VIPBPC-157GHK-CuGlutathione (GSH)PEASelankTB-500Thymosin Beta-4

Metabolic

L-Carnitine

Fat oxidation & endurance

Mechanism

Carnitine shuttle for fatty-acid transport into mitochondria

Typical dose

200-500 mg daily

Cycle length

4-12 weeks

Frequency

Daily

Clinical benefits

Fat oxidation
Endurance enhancement
Muscle recovery

Synergistic compounds

GLP-1sMOTS-cNAD+5-Amino-1MQAOD-9604SS-31Tesamorelin

Cosmetic

Melanotan I

MC1R-selective photoprotector

Mechanism

Selective MC1R agonist; eumelanin synthesis; DNA repair enhancement

Typical dose

500-1000 mcg 2×/week

Cycle length

2-8 weeks

Frequency

2×/week

Clinical benefits

UV-independent tanning
Photoprotection
DNA repair support

Synergistic compounds

GHK-CuKPVNAD+

Cosmetic

Melanotan II

Non-selective melanocortin agonist (unapproved)

Mechanism

Cyclic peptide; activates MC1R/MC3R/MC4R/MC5R — tanning, sexual function, appetite suppression

Typical dose

250-500 mcg daily

Cycle length

1-4 weeks

Frequency

Daily

Clinical benefits

Tanning without UV
Sexual function
Appetite reduction

Synergistic compounds

Growth Hormone Axis

MK-677

Oral ghrelin-receptor GH secretagogue

Mechanism

Small-molecule GHS-R1a agonist; raises GH and IGF-1 orally

Typical dose

10-25 mg daily

Cycle length

8-104 weeks

Frequency

Daily

Clinical benefits

Lean mass gain
GH/IGF-1 elevation
Oral convenience

Synergistic compounds

BPC-157NAD+

Metabolic

MOTS-c

Mitochondrial peptide for metabolic flexibility

Mechanism

AMPK activation, metabolic flexibility enhancement

Typical dose

5-10 mg 2-3x-weekly

Cycle length

8-12 weeks

Frequency

2-3x-weekly

Clinical benefits

Fat oxidation
Training tolerance
Metabolic flexibility

Synergistic compounds

GLP-1sNAD+SS-31L-Carnitine5-Amino-1MQTesamorelin

Anti-Aging

NAD+

Foundational energy substrate

Mechanism

Universal cofactor for ATP and sirtuin activity

Typical dose

50-250 mg 2-3x-weekly

Cycle length

2-12 weeks

Frequency

2-3x-weekly

Clinical benefits

Restores cellular energy
Supports DNA repair
Enhances mitochondrial function

Synergistic compounds

GLP-1sMOTS-cSS-31L-CarnitineBPC-1575-Amino-1MQGlutathione (GSH)Thymosin α-1

HPTA Axis

Oxytocin

Bonding & autonomic state signal

Mechanism

OXTR agonism; threat processing, social salience, autonomic state

Typical dose

10-20 IU as needed

Cycle length

On-demand

Frequency

As needed

Clinical benefits

Anxiety/social context support
HPA recovery
Libido (off-label)

Synergistic compounds

DSIPPinealonSelankPT-141VIP

Cognitive & Nootropic

P21

Neuroplasticity enhancer

Mechanism

BDNF upregulation, synaptic plasticity enhancement

Typical dose

100-500 mcg daily

Cycle length

4-8 weeks

Frequency

Daily

Clinical benefits

Motor learning
Neuroplasticity
Post-TBI recovery

Synergistic compounds

SemaxNAD+SS-31

Healing & Tissue Repair

PEA

Anti-inflammatory fatty-acid amide (oral)

Mechanism

PPAR-α activation, mast-cell ALIA signaling, TRPV1 modulation

Typical dose

300-600 mg bid

Cycle length

8-12 weeks

Frequency

BID

Clinical benefits

Chronic pain reduction
Neuropathic pain support
Gut-barrier modulation

Synergistic compounds

BPC-157Glutathione (GSH)KPVSelankVIP

Anti-Aging

Pinealon

CNS trophic support

Mechanism

Oligopeptide regulatory effects on brain tissue

Typical dose

1-2 mg daily

Cycle length

2-3 weeks

Frequency

Daily

Clinical benefits

Cognitive support
Neuroprotection
Stress resilience

Synergistic compounds

DSIPEpitalonOxytocinSelankSemaxVIP

HPTA Axis

PT-141

Sexual desire signal (FDA-approved HSDD)

Mechanism

Non-selective melanocortin agonist; central arousal circuitry

Typical dose

1.75 mg as needed

Cycle length

On-demand

Frequency

As needed

Clinical benefits

Desire & arousal (women)
Erectile support (off-label)
On-demand dosing

Synergistic compounds

Oxytocin

GLP-1 Agonists

Retatrutide

Triple agonist for aggressive fat loss

Mechanism

GLP-1 (satiety), GIP (insulinotropic), glucagon (lipolysis) agonist

Typical dose

0.3-12 mg weekly

Cycle length

12-48 weeks

Frequency

Weekly

Clinical benefits

Aggressive fat loss
Energy expenditure
Satiety control

Synergistic compounds

NAD+TesamorelinMOTS-cL-Carnitine5-Amino-1MQAOD-9604IpamorelinSS-31

Cognitive & Nootropic

Selank

Anxiolytic & stress resilience

Mechanism

Tuftsin analog, GABAergic modulation, anti-inflammatory

Typical dose

250-500 mcg daily

Cycle length

2-4 weeks

Frequency

Daily

Clinical benefits

Anxiety reduction
Stress resilience
Improved mood

Synergistic compounds

SemaxAdamaxDSIPKPVOxytocinPinealonThymosin α-1VIP

GLP-1 Agonists

Semaglutide

GLP-1 for weight loss & CV protection

Mechanism

GLP-1R agonism with long half-life

Typical dose

0.1-2.4 mg weekly

Cycle length

12-68 weeks

Frequency

Weekly

Clinical benefits

Weight loss
Glycemic control
CV risk reduction

Synergistic compounds

NAD+MOTS-cL-CarnitineTesamorelinAOD-9604Ipamorelin

Cognitive & Nootropic

Semax

Cognitive drive & focus

Mechanism

ACTH analog, BDNF up-regulation, dopaminergic modulation

Typical dose

200-600 mcg daily

Cycle length

2 weeks

Frequency

Daily

Clinical benefits

Cognitive drive
Focus enhancement
Post-TBI support

Synergistic compounds

SelankP21DSIPNAD+PinealonSS-31

Growth Hormone Axis

Sermorelin

Pulsatile GH release

Mechanism

Pulsatile GH release from pituitary, modest IGF-1 rise

Typical dose

200-500 mcg daily

Cycle length

8-12 weeks

Frequency

Daily

Clinical benefits

Sleep quality
Enhanced recovery
Modest body composition

Synergistic compounds

IpamorelinGHRP-2GHRP-6NAD+

Anti-Aging

SS-31

Mitochondrial function optimizer

Mechanism

Binds cardiolipin, stabilizes cristae, improves electron transport

Typical dose

5-10 mg daily

Cycle length

8-12 weeks

Frequency

Daily

Clinical benefits

Reduces fatigue
Improves HRV
Lowers post-exertional malaise

Synergistic compounds

MOTS-cNAD+L-CarnitineP21SemaxTB-500

Healing & Tissue Repair

TB-500

Soft-tissue healing accelerator

Mechanism

Actin-sequestering, cell migration, angiogenesis

Typical dose

2-4 mg 2×/week

Cycle length

4-8 weeks

Frequency

2×/week

Clinical benefits

Soft-tissue healing
Post-surgical recovery
Anti-inflammatory

Synergistic compounds

BPC-157GHK-CuNAD+CartalaxKPVSS-31

Growth Hormone Axis

Tesamorelin

Visceral fat reduction via GH

Mechanism

Stimulates pituitary GH release, IGF-1 elevation, lipolysis

Typical dose

1-2 mg daily

Cycle length

12-16 weeks

Frequency

Daily

Clinical benefits

Visceral fat reduction
Improved body composition
Enhanced recovery

Synergistic compounds

GLP-1sIpamorelinNAD+5-Amino-1MQAOD-9604BPC-157L-CarnitineMOTS-c

Immune Modulators

Thymalin

Russian thymic extract complex

Mechanism

Short thymic peptides (KE, EW, EDP fractions); transcription and hematopoietic signaling

Typical dose

5-20 mg daily

Cycle length

4-11 days

Frequency

Daily

Clinical benefits

Immune restoration
Autoimmune baseline support
Acute illness recovery

Synergistic compounds

Epitalon

Healing & Tissue Repair

Thymosin Beta-4

Full-length TB-4 (verify vs TB-500 fragment)

Mechanism

G-actin sequestration, Ac-SDKP release, anti-fibrotic signaling

Typical dose

2-4 mg 2×/week

Cycle length

4-8 weeks

Frequency

2×/week

Clinical benefits

Soft-tissue repair
Anti-fibrotic action
Wound and ophthalmic trial use

Synergistic compounds

BPC-157GHK-CuKPV

Immune Modulators

Thymosin α-1

Immune modulation & post-viral support

Mechanism

Enhances T-cell function, upregulates MHC, rebalances Th1/Th2

Typical dose

1.6 mg daily

Cycle length

12-24 weeks

Frequency

Daily

Clinical benefits

Infection frequency reduction
Faster viral recovery
Improved energy

Synergistic compounds

NAD+Glutathione (GSH)SelankThymulin

Immune Modulators

Thymulin

Zinc-dependent thymic immune signal

Mechanism

T-cell differentiation, NK cell activity, neuroendocrine stress-immune crosstalk

Typical dose

5-10 mg daily

Cycle length

1-2 weeks

Frequency

Daily

Clinical benefits

T-cell maturation
Immune-stress balance
NK cell support

Synergistic compounds

Glutathione (GSH)NAD+Thymosin α-1

GLP-1 Agonists

Tirzepatide

Dual agonist for weight & T2D control

Mechanism

GLP-1 satiety/gastric delay + GIP insulinotropic effects

Typical dose

0.5-15 mg weekly

Cycle length

12-72 weeks

Frequency

Weekly

Clinical benefits

Weight loss
Glycemic control
OSA improvement

Synergistic compounds

NAD+MOTS-cL-CarnitineTesamorelinAOD-9604Ipamorelin

Immune Modulators

VIP

MCAS & dysautonomia support

Mechanism

VPAC receptor activation; anti-inflammatory; mast-cell modulation

Typical dose

25-200 mcg daily

Cycle length

4-12 weeks

Frequency

Daily

Clinical benefits

Heat intolerance reduction
Brain fog reduction
HRV improvement

Synergistic compounds

KPVDSIPGlutathione (GSH)NAD+OxytocinPEAPinealonSelank